Recombinant vaccines for the prevention of human papillomavirus infection and cervical cancer

This publication has 96 references indexed in Scilit:

• Papillomaviruses in the causation of human cancers — a brief historical account
  Virology, 2009
• Vaccination with HPV16 L2E6E7 fusion protein in GPI-0100 adjuvant elicits protective humoral and cell-mediated immunity
  Vaccine, 2008
• Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
  Published by Elsevier ,2008
• An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results
  Vaccine, 2008
• Intravaginal Immunization of Mice with Recombinant Salmonella enterica Serovar Typhimurium Expressing Human Papillomavirus Type 16 Antigens as a Potential Route of Vaccination against Cervical Cancer
  Infection and Immunity, 2008
• Human papillomavirus L1 protein expressed in tobacco chloroplasts self‐assembles into virus‐like particles that are highly immunogenic
  Plant Biotechnology Journal, 2008
• Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2
  Proceedings of the National Academy of Sciences, 2008
• Salmonella enterica Serovar Typhi Ty21a Expressing Human Papillomavirus Type 16 L1 as a Potential Live Vaccine against Cervical Cancer and Typhoid Fever
  Clinical and Vaccine Immunology, 2007
• Binding and neutralization efficiencies of monoclonal antibodies, Fab fragments, and scFv specific for L1 epitopes on the capsid of infectious HPV particles
  Virology, 2007
• Plant-Produced Cottontail Rabbit Papillomavirus L1 Protein Protects against Tumor Challenge: a Proof-of-Concept Study
  Clinical and Vaccine Immunology, 2006